FK506 and cyclosporin, molecular probes for studying intracellular signal transduction
- 30 June 1993
- journal article
- review article
- Published by Elsevier BV in Immunology Today
- Vol. 14 (6), 290-295
- https://doi.org/10.1016/0167-5699(93)90048-p
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.The Journal of Experimental Medicine, 1992
- Identification of calcineurin as a key signalling enzyme in T-lymphocyte activationNature, 1992
- FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurinNature, 1992
- Cyclosporin A, FK-506, and Rapamycin: Pharmacologic Probes of Lymphocyte Signal TransductionAnnual Review of Immunology, 1992
- The mechanism of action of cyclosporin A and FK506Immunology Today, 1992
- Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: One in the presence and one in the absence of CsACell, 1991
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- T cell antigen receptor activation pathways: The tyrosine kinase connectionCell, 1991
- Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A?The Journal of Experimental Medicine, 1991
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989